Going Concern (Details Narrative)								3 Months Ended	6 Months Ended
Going Concern (Details Narrative)	Oct. 14, 2016 USD ($)	Oct. 01, 2016 GBP (£)	Jul. 12, 2016 USD ($)	Mar. 23, 2016 USD ($)	Mar. 21, 2016 USD ($)	Dec. 28, 2015 USD ($) $ / shares shares	Apr. 30, 2012 USD ($)	Oct. 31, 2015 USD ($)	Oct. 31, 2016 USD ($) $ / shares shares	Oct. 31, 2016 GBP (£) shares	Oct. 31, 2016 EUR (€)	Jul. 07, 2016 USD ($)	Apr. 30, 2016 USD ($)	Jan. 22, 2016 USD ($)	Jun. 19, 2015 USD ($)
Working capital deficit									$ 1,319,224
Accumulated deficit									$ 3,435,046				$ 3,089,331
Repayment of debt				$ 33,500			$ 1,500
Business combination consideration transferred								$ 2,500
Euro [Member] \| Venn Life Sciences [Member]
Cash reserves and a bank loan facility \| €											€ 1,000,000
Mercuriali Ltd [Member]
Advance from related party														$ 90,000
Integumen Limited [Member]
Reserve for interim costs	$ 25,000
Number of ordinary shares received \| shares									2,632,868	2,632,868
Percentage of accrued interest per annum									80.00%		80.00%
Asset purchase agreement, description									The APA provides that 80 per cent of the Consideration Shares should be issued on completion of the APA and the remaining 20 per cent (subject to an adjustment depending on the value of the assumed liabilities) should be issued within 30 days of Admission of Integumen to AIM.	The APA provides that 80 per cent of the Consideration Shares should be issued on completion of the APA and the remaining 20 per cent (subject to an adjustment depending on the value of the assumed liabilities) should be issued within 30 days of Admission of Integumen to AIM.
Integumen Limited [Member] \| November 16, 2016 [Member]
Reserve for interim costs									$ 30,000
Integumen Limited [Member] \| December 2, 2016 [Member]
Number of ordinary shares received \| shares									2,632,868	2,632,868
Business combination consideration transferred									$ 3,939,000
Assumption of certain liabilities									416,272
Prepayment of note									$ 100,000
Integumen Limited [Member] \| GBP [Member] \| December 2, 2016 [Member]
Business acquisition share price per share \| $ / shares									$ 1
Business combination consideration transferred \| £										£ 3,030,000
Assumption of certain liabilities \| £										320,209
Prepayment of note \| £										£ 76,923
Integumen Limited [Member] \| Option Agreement [Member]
Proceeds from loans			$ 100,000
Secured promissory note												$ 100,000
Integumen Limited [Member] \| Option Agreement [Member] \| Minimum [Member] \| GBP [Member]
Exercise of option \| £		£ 3,030,000
Vis Vires Group Inc [Member]
Value of convertible promissory note issued															$ 43,000
Conversion of promissory note into shares, value						$ 12,000
Debt conversion price per share \| $ / shares						$ 0.0017
Conversion of promissory note shares \| shares						7,058,824
Mercuriali [Member] \| Loan Agreement (Amendment 5) [Member] \| Minimum [Member]
Proceeds from loans					$ 90,000
Mercuriali [Member] \| Loan Agreement (Amendment 5) [Member] \| Maximum [Member]
Proceeds from loans					$ 150,000

Enhance Skin Products Inc 10-Q